<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34463956</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>253</StartPage><EndPage>262</EndPage><MedlinePgn>253-262</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.27309</ELocationID><Abstract><AbstractText>There is an established literature on the symptoms and complications of COVID-19 but the after-effects of COVID-19 are not well understood with few studies reporting persistent symptoms and quality of life. We aim to evaluate the pooled prevalence of poor quality of life in post-acute COVID-19 syndrome (PCS) and conducted meta-regression to evaluate the effects of persistent symptoms and intensive care unit (ICU) admission on the poor quality of life. We extracted data from observational studies describing persistent symptoms and quality of life in post-COVID-19 patients from March 10, 2020, to March 10, 2021, following PRISMA guidelines with a consensus of two independent reviewers. We calculated the pooled prevalence with 95% confidence interval (CI) and created forest plots using random-effects models. A total of 12 studies with 4828 PCS patients were included. We found that amongst PCS patients, the pooled prevalence of poor quality of life (EQ-VAS) was (59%; 95% CI: 42%-75%). Based on individual factors in the EQ-5D-5L questionnaire, the prevalence of mobility was (36, 10-67), personal care (8, 1-21), usual quality (28, 2-65), pain/discomfort (42, 28-55), and anxiety/depression (38, 19-58). The prevalence of persistent symptoms was fatigue (64, 54-73), dyspnea (39.5, 20-60), anosmia (20, 15-24), arthralgia (24.3, 14-36), headache (21, 3-47), sleep disturbances (47, 7-89), and mental health (14.5, 4-29). Meta-regression analysis showed the poor quality of life was significantly higher among post-COVID-19 patients with ICU admission (p&#x2009;=&#x2009;0.004) and fatigue (p&#x2009;=&#x2009;0.0015). Our study concludes that PCS is associated with poor quality of life, persistent symptoms including fatigue, dyspnea, anosmia, sleep disturbances, and worse mental health. This suggests that we need more research on PCS patients to understand the risk factors causing it and eventually leading to poor quality of life.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Preeti</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9427-0225</Identifier><AffiliationInfo><Affiliation>Department of Public Health, Icahn school of Medicine at Mount Sinai, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Karan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Cooper Medical School of Rowan University, Camden, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Candida</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Public Health, Icahn school of Medicine at Mount Sinai, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaiswal</LastName><ForeName>Richa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tirupathi</LastName><ForeName>Raghavendra</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Keystone Health, Chambersburg, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillai</LastName><ForeName>Shreejith</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Henry Ford Health System, Detroit, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Urvish</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Public Health, Icahn school of Medicine at Mount Sinai, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">health-related quality of life</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">persistent symptoms</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>The authors declare that there are no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>31</Day><Hour>13</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34463956</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
COVID&#x2010;19 Coronavirus Pandemic
. Worldometer. 2020.&#xa0;Accessed March 20, 2021. https://www.worldometers.info/coronavirus/#countries
</Citation></Reference><Reference><Citation>Patel U, Malik P, Usman MS, et al. Age&#x2010;adjusted risk factors associated with mortality and mechanical ventilation utilization amongst COVID&#x2010;19 hospitalizations&#x2014;a systematic review and meta&#x2010;analysis. SN Compr Clin Med. 2020:1&#x2010;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7456201</ArticleId><ArticleId IdType="pubmed">32904541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur N, Gupta I, Singh H, et al. Epidemiological and clinical characteristics of 6635 COVID&#x2010;19 patients: a pooled analysis. SN Compr Clin Med. 2020;2(8):1048&#x2010;1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7343407</ArticleId><ArticleId IdType="pubmed">32838160</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID&#x2010;19 and multiorgan response. Curr Probl Cardiol. 2020;45(8):100618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187881</ArticleId><ArticleId IdType="pubmed">32439197</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID&#x2010;19 and multiorgan failure: a narrative review on potential mechanisms. J Mol Histol. 2020;51(6):613&#x2010;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533045</ArticleId><ArticleId IdType="pubmed">33011887</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Gourna Paleoudis E, Lesky&#x2010;Di Bari, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID&#x2010;19 infection. PLoS One. 2020;15(12):e0243882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>
(IDSA) IDSoA
. Post COVID/long COVID. 2021.&#xa0;Accessed March 1, 2021. https://www.idsociety.org/covid-19-real-time-learning-network/disease-manifestations--complications/post-covid-syndrome/#:%7E:text=Preliminary%20reports%20indicate%20some%20patients,to%2Dsevere%20disease
</Citation></Reference><Reference><Citation>Mahase E. Covid&#x2010;19: What do we know about &#x201c;long covid&#x201d;? BMJ. 2020;370:m2815.</Citation><ArticleIdList><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, et al. Respiratory and psychophysical sequelae among patients with COVID&#x2010;19 four months after hospital discharge. JAMA Netw Open. 2021;4(1):e2036142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Moreno E, Cari&#xf1;ena A, et al. Quality of life, functional status, and persistent symptoms after intensive care of COVID&#x2010;19 patients. Br J Anaesth. 2021;126(3):e110&#x2010;e113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Arab&#x2010;Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. Health&#x2010;related quality of life and its associated factors in COVID&#x2010;19 patients. Osong Public Health Res Perspect. 2020;11(5):296&#x2010;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577388</ArticleId><ArticleId IdType="pubmed">33117634</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n&#x2010;Tejada CE, Herrera&#x2010;Garc&#xed;a CF, Godina&#x2010;Gonz&#xe1;lez S, et al. Persistence of COVID&#x2010;19 symptoms after recovery in Mexican population. Int J Environ Res Public Health. 2020;17(24).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7765113</ArticleId><ArticleId IdType="pubmed">33327641</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Jahdhami I, Al&#x2010;Naamani K, Al&#x2010;Mawali A. The post&#x2010;acute COVID&#x2010;19 syndrome (long COVID). Oman Med J. 2021;36(1):e220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7838343</ArticleId><ArticleId IdType="pubmed">33537155</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID&#x2010;19 infection: a cross&#x2010;sectional evaluation. J Med Virol. 2021;93(2):1013&#x2010;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post&#x2010;discharge persistent symptoms and health&#x2010;related quality of life after hospitalization for COVID&#x2010;19. J Infect. 2020;81(6):e4&#x2010;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I, H&#xe4;llqvist J, Gilmour K, Grandjean L, Mills K, Heywood W. The long tail of Covid&#x2010;19?&#x2014;the detection of a prolonged inflammatory response after a SARS&#x2010;CoV&#x2010;2 infection in asymptomatic and mildly affected patients [version 2; peer review: 2 approved]. F1000Res. 2021;9:1349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. SARS CoV&#x2010;2 related microvascular damage and symptoms during and after COVID&#x2010;19: Consequences of capillary transit&#x2010;time changes, tissue hypoxia and inflammation. Physiol Rep. 2021;9(3):e14726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow MK&#x2010;S, Kwek DS&#x2010;K, Ng AW&#x2010;K, Ong K&#x2010;C, Kaw GJ&#x2010;L, Lee LS&#x2010;U. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol. 2005;63(2):197&#x2010;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post&#x2010;SARS syndrome; a case&#x2010;controlled study. BMC Neurol. 2011;11:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AM, Wong JG, McAlonan GM, et al. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can J Psychiatry. 2007;52(4):233&#x2010;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">17500304</ArticleId></ArticleIdList></Reference><Reference><Citation>Batawi S, Tarazan N, Al&#x2010;Raddadi R, et al. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS). Health Qual Life Outcomes. 2019;17(1):101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6560892</ArticleId><ArticleId IdType="pubmed">31186042</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five&#x2010;level version of EQ&#x2010;5D (EQ&#x2010;5D&#x2010;5L). Qual Life Res. 2011;20(10):1727&#x2010;1736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta&#x2010;analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1&#x2010;e34.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O'Malley M, Malani AN, Prescott HC. Sixty&#x2010;day outcomes among patients hospitalized with COVID&#x2010;19. Ann Intern Med. 2020;174:576&#x2010;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Group ftGAC&#x2010;P&#x2010;ACS. Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324(6):603&#x2010;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto&#x2010;Mancuso J, Wood J, et al. Post&#x2010;acute COVID&#x2010;19 syndrome negatively impacts health and wellbeing despite less severe acute infection. medRxiv. 2020:2020.2011.2004.20226126.</Citation></Reference><Reference><Citation>Valent A, Dudoignon E, Ressaire Q, D&#xe9;pret F, Plaud B. Three&#x2010;month quality of life in survivors of ARDS due to COVID&#x2010;19: a preliminary report from a French academic centre. Anaesth Crit Care Pain Med. 2020;39(6):740&#x2010;741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547571</ArticleId><ArticleId IdType="pubmed">33049394</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. &#x2018;Long&#x2010;COVID&#x2019;: a cross&#x2010;sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID&#x2010;19. Thorax. 2021;76(4):396&#x2010;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2010;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno&#x2010;P&#xe9;rez O, Merino E, Leon&#x2010;Ramirez J&#x2010;M, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378&#x2010;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention (CDC)
. Management of visitors to healthcare facilities in the context of COVID&#x2010;19: non&#x2010;US healthcare settings. 2020.&#xa0;Accessed March 1, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/hcf-visitors.html
</Citation></Reference><Reference><Citation>Chang MC, Park D. Incidence of post&#x2010;traumatic stress disorder after coronavirus disease. Healthcare. 2020;8(4):373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7712968</ArticleId><ArticleId IdType="pubmed">33008081</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang T&#x2010;J, Rabheru K, Peisah C, Reichman W, Ikeda M. Loneliness and social isolation during the COVID&#x2010;19 pandemic. Int Psychogeriatr. 2020;32(10):1217&#x2010;1220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7306546</ArticleId><ArticleId IdType="pubmed">32450943</ArticleId></ArticleIdList></Reference><Reference><Citation>Amruta N, Chastain WH, Paz M, et al. SARS&#x2010;CoV&#x2010;2 mediated neuroinflammation and the impact of COVID&#x2010;19 in neurological disorders. Cytokine Growth Factor Rev. 2021;58:1&#x2010;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894219</ArticleId><ArticleId IdType="pubmed">33674185</ArticleId></ArticleIdList></Reference><Reference><Citation>Dicpinigaitis PV, Canning BJ. Is there (will there be) a post&#x2010;COVID&#x2010;19 chronic cough? Lung. 2020;198(6):863&#x2010;865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665087</ArticleId><ArticleId IdType="pubmed">33188436</ArticleId></ArticleIdList></Reference><Reference><Citation>
Jiang K. How COVID&#x2010;19 causes loss of smell. 2020. Accessed March 10, 2021.https://hms.harvard.edu/news/how-covid-19-causes-loss-smell
</Citation></Reference><Reference><Citation>Gori A, Leone F, Loffredo L, et al. COVID&#x2010;19&#x2010;related anosmia: the olfactory pathway hypothesis and early intervention. Front Neurol. 2020;11:956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511833</ArticleId><ArticleId IdType="pubmed">33013637</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Li J, Liu H, et al. Long&#x2010;term bone and lung consequences associated with hospital&#x2010;acquired severe acute respiratory syndrome: a 15&#x2010;year follow&#x2010;up from a prospective cohort study. Bone Res. 2020;8(1):8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta&#x2010;analysis with comparison to the COVID&#x2010;19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2010;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>